How many insider declarations has Bianco James A. filed?

Bianco James A. has filed 3 public insider declarations with SEC (Form 4).

What is Bianco James A.'s role?

Bianco James A.'s reported role is not specified by the regulator across the filings.

Which companies does Bianco James A. report trades for?

Bianco James A. reports trades for 3 companies, including Kintara Therapeutics, Inc..

← Executives ★ Sign in to follow

BJ

Bianco James A.

CEO

·SEC (Form 4)

Kintara Therapeutics, Inc.CTI Biopharma CORP TuHURA Biosciences, Inc./NV

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Bianco James A.. Officer active across 3 companies, notably Kintara Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Activity tracked since 18 October 2024. The latest transaction was filed on 28 May 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Bianco James A.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kintara Therapeutics, Inc. (US)CTI Biopharma CORP (US)TuHURA Biosciences, Inc./NV (US)

申报3 总计

●

Bianco James A.

Chief Executive Officer高管2026年5月28日TuHURA Biosciences, Inc./NV

0SEC ↗

150,000 股0Common StockSEC:0000897069-26-001285:0

◆

Bianco James A.

Chief Executive Officer高管2024年10月18日Kintara Therapeutics, Inc.

0SEC ↗

2,323,307 股0Common StockSEC:0000897069-24-001996:0

▼

BIANCO JAMES A

President and CEO高管2016年1月29日CTI Biopharma CORP

0SEC ↗

10,000 股Common StockSEC:0000891293-16-000093:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

BJ

Bianco James A.

CEO

·SEC (Form 4)

Kintara Therapeutics, Inc.CTI Biopharma CORP TuHURA Biosciences, Inc./NV

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Bianco James A.. Officer active across 3 companies, notably Kintara Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Activity tracked since 18 October 2024. The latest transaction was filed on 28 May 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.